Liposomes have gained increased attention as systemic drug delivery vehicles following
recent regulatory approvals of several vesicle-formulated drugs. These products have …

Liposomes are tiny lipid-based vesicles composed of one or more lipid bilayers, which
facilitate the encapsulation of hydrophilic, lipophilic, and amphiphilic biological active …

Sažetak Liposomes have been widely investigated since 1970 as drug carriers for improving
the delivery of therapeutic agents to specific sites in the body. As a result, numerous …

Liposomes are being increasingly utilized to deliver drugs, enzymes, antisense
oligonucleotides, and genes to various therapeutic targets. Liposome-mediated delivery of …

Liposomes have shown great potential as a drug delivery system. An assortment of
molecules, including peptides and proteins, have been incorporated in liposomes, which …

The drug molecules can be classified into four categories, ie highly hydrophilic, highly
lipophilic, amphiphilic and those with biphasic insolubility. These are located differently in …

Liposomes were first described nearly 40 years ago and have been useful models for
studying the physical chemistry of lipid bilayers and the biology of the cell membrane (rev. in …

Liposomes are the leading drug delivery systems for the systemic (iv.) administration of
drugs. There are now liposomal formulations of conventional drugs that have received …

Association of drugs with carriers such as liposomes has marked effects on both the
pharmacokinetic profiles of the carrier and of the carrier-associated drug. In general …

Liposomes have matured as a delivery system for therapeutic agents. It has taken two
decades to develop the liposome carrier concept to a pharmaceutical product level, but …